Commercial
Advanced Search
  
  
  
  
  
  
  
  
  
  
  
MPattachmentdataPub
  
8604ea67-4253-43cf-8958-2cef34147847.aspx
  
4584MedicalandSurgicalTreatmentofTemporomandibularJointDisorder07.08.03hMedicine (07)07.08.03h07.08.03Medical and Surgical Treatment of Temporomandibular Joint DisorderMedical and Surgical Treatment of Temporomandibular Joint Disorder9/9/2022 10:00 AM8604ea67-4253-43cf-8958-2cef34147847
10/10/2022
04e64f12-2f0b-45ff-a1ab-87a4c36e1445.aspx
  
4593Eculizumab(Soliris®)andRelatedBiosimilars,Ravulizumab-cwvz(Ultomiris®)08.00.84iPharmacy (08)08.00.84i08.00.84Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)9/19/2022 1:00 PM04e64f12-2f0b-45ff-a1ab-87a4c36e1445
10/17/2022
a4ce83b3-04fd-4934-a94a-419b71e6137b.aspx
  
4600PneumaticCompressionTherapyDevices05.00.01nDME (05)05.00.01n05.00.01Pneumatic Compression Therapy DevicesPneumatic Compression Therapy Devices9/23/2022 9:00 AMa4ce83b3-04fd-4934-a94a-419b71e6137b
{"4601": {"Id":4601,"MPAttachmentLetter":"A","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":6546,"PolicyAttachmentPageName":"517ec520-9dfc-4aec-9f05-9186a2860d78"},}
10/24/2022
b8c2e7b3-d192-479a-8b81-5a56c4e44e71.aspx
  
4575Aprepitant(Cinvanti™),FosaprepitantDimeglumine(Emend®),Granisetron(Sustol®),andRolapitant(Varubi®)08.01.41dPharmacy (08)08.01.41d08.01.41Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)8/30/2022 10:00 AMb8c2e7b3-d192-479a-8b81-5a56c4e44e71
{"4576": {"Id":4576,"MPAttachmentLetter":"A","Title":"Risk of Emesis Without Prophylaxis: Intravenous and Oral Antineoplastic Agents","MPPolicyAttachmentInternalSourceId":6528,"PolicyAttachmentPageName":"7233510e-de6a-488a-8d85-fbdbb57c6dad"},}
11/29/2022